New technology can detect melanoma cancer cells without a scalpel

May is Melanoma Awareness Month. One in five Americans�develop skin cancer�during their lifetime, and every hour of every day one American�dies from melanoma. It?s not only one of the most common cancers diagnosed in the U.S., but also the�deadliest of skin cancers. That's why early detection is so important. Dr. Ronald Moy introduces the new DermTech Pigmented Lesion Assay (PLA), a smart sticker applied to the surface of the skin that analyzes moles (in a non-invasive way, without a scalpel). The smart sticker has less than 1% chance of missing melanoma and is covered by Blue Cross, Blue Shield and Medicare.